Andrew Webb - Concepedia

Author

Andrew Webb

Royal Marsden NHS Foundation Trust ORCID

Also Known As

A R Webb, A Webb, A. R. Webb, A. Webb, A. webb, A.R. WEBB, A.R. Webb, ANDREW R. WEBB, Abigail Webb, Alexandra L.J. Webb

166

Publications

7.8K

Citations

H-Index

Concepts

All Affiliations

Royal Marsden NHS Foundation Trust Royal Marsden Hospital University College London Institute of Cancer Research North Middlesex Hospital

About

Andrew Webb is an author at Royal Marsden NHS Foundation Trust specializing in medicine, oncology, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	31	4.1K
2	Engineering	4	4	258
3	Health Sciences	3	3	356
4	Humanities	1	1	28
5	Management	1	1	34

Andrew Webb

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study Allan T. van Oosterom, Ian Judson, Jaap Verweij, The Lancet OncologyGastrointestinal OncologyMedicinePathologyCancer Treatment	2001	1.3K
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. Andrew Webb, David Cunningham, J.H. Scarffe, Journal of Clinical Oncology	1997	872
BCL-2 antisense therapy in patients with non-Hodgkin lymphoma Andrew Webb, David Cunningham, Finbarr E. Cotter, The Lancet Bcl-2 Antisense TherapyLymphoid NeoplasiaMedicineImmunologyAdult T-cell Leukemia-lymphoma	1997	498
Phase I Clinical and Pharmacokinetic Study of Bcl-2 Antisense Oligonucleotide Therapy in Patients With Non-Hodgkin’s Lymphoma Justin S. Waters, Andrew Webb, David Cunningham, Journal of Clinical Oncology	2000	455
Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer Matthew J. Ward, Stephen M. Thirdborough, Toby Mellows, British Journal of Cancer	2013	383
Intra-operative gut mucosal hypoperfusion is associated with increased post-operative complications and cost Michael G. Mythen, Andrew Webb Intensive Care Medicine Colorectal SurgeryGastroenterologyIncreased Post-operative ComplicationsVisceral SurgerySurgery	1994	369
Comparison of commonly used clinical indicators of hypovolaemia with gastrointestinal tonometry Colin Hamilton-Davies, Michael G. Mythen, J Salmon, Intensive Care Medicine Gastrointestinal TonometryUsed Clinical IndicatorsGastroenterologyMedicineAnesthesiology	1997	300
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial Justin S. Waters, A. Norman, David Cunningham, British Journal of Cancer	1999	278
Hand Grip Dynamometry as a Predictor of Postoperative Complications Reappraisal Using Age Standardized Grip Strengths Andrew Webb, Lindsey A. Newman, Martine Taylor, Journal of Parenteral and Enteral Nutrition Upper ExtremitySurgeryInjury PreventionPre-operative Nutritional SupportOrthopaedic Surgery	1989	201
A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer Ian Chau, A. Norman, David Cunningham, Annals of Oncology Surgical OncologyBolus Fluorouracil/leucovorinMedicineGastroenterologyColorectal Cancer	2005	185

Page 1